This inventor holds 3 USPTO granted patents. Top assignees: University of Massachusetts, Boston Probes, Inc.. Active years: 1998-2011.
Company Filing History:
Years Active: 1998-2011
Title: Krishan L Taneja: Innovator in Chromosome Detection Technologies
Introduction
Krishan L Taneja is a notable inventor based in Northborough, MA (US). He has made significant contributions to the field of chromosome detection through his innovative inventions. With a total of 3 patents, Taneja's work focuses on developing advanced methods and kits for the detection of human chromosomes.
Latest Patents
Taneja's latest patents include groundbreaking technologies such as non-nucleic acid probes, probe sets, methods, and kits for detecting individual human chromosomes. His inventions allow for the detection, identification, or quantitation of chromosomes X, Y, 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 16, 17, 18, 20, and 21. These technologies are particularly useful in multiplex ISH and FISH assays, enabling the simultaneous detection of multiple chromosomes in a single assay. The probes are designed to be labeled with independently detectable fluorophores, enhancing the accuracy and efficiency of chromosome analysis. Additionally, Taneja has developed methods for detecting trinucleotide repeat expansions, which are crucial for identifying genetic disorders.
Career Highlights
Throughout his career, Taneja has worked with esteemed organizations such as the University of Massachusetts and Boston Probes, Inc. His expertise in chromosome detection has positioned him as a leader in the field, contributing to advancements in clinical diagnostics and prenatal screening.
Collaborations
Taneja has collaborated with notable scientists, including Robert H Singer and Joan C Politz. These partnerships have further enriched his research and development efforts in chromosome detection technologies.
Conclusion
Krishan L Taneja's innovative work in chromosome detection has made a significant impact in the field of genetics and diagnostics. His patents reflect a commitment to advancing medical technology and improving patient outcomes.
